Iminosugars as possible broad spectrum anti hepatitis virus agents: The glucovirs and alkovirs

Antiviral Chemistry and Chemotherapy

Volumn 12, Issue 6, 2001, Pages 317-325

  Block, Timothy M ^a   Jordan, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antivirals; Glycan processing; Hepatitis B; Hepatitis C; Imino sugars; Protein folding

Indexed keywords

ANTIVIRUS AGENT; GLUCOSIDASE; GLUCOSIDASE INHIBITOR; IMINOSUGAR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ENZYME INHIBITION; HEPATITIS B VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN CELL; IC 50; OLIGOMERIZATION; PRIORITY JOURNAL; REVIEW;

EID: 0035737942     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020101200601     Document Type: Review

References (40)

1. Epidemiology of hepatitis C
2. Hepatitis B Virus secretion is inhibited by the imino sugar, N-butylnojirimycin
3. Treatment of woodchucks chronically infected with woodchuck hepatitis virus with protein folding inhibitors
4. Processing of N-linked oligosaccharides on the measles virus glycoproteins: Importance for antigenicity and for production of infectious virus particles
5. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfoding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers
6. Emergence and takeover of YMDD motif mutant hepatitis B virus during long term lamivudinc therapy and re-takeover by wild type virus after cessation of therapy
7. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins
8. a-glucosidase inhibitors reduce Dengue Virus production by affecting the initial steps of virion morphogenesis in the encloplasmic reticulum
9. Resistance of hepatitis B virus to antiviral drugs: Current aspects and directions for future investigation
10. Hepatitis c virus glycoprotein folding: Disulfide bond formation and association with calnexin
11. Study of the mechanism of antiviral action of iminosugar derivatives against bovine Viral Diarrhea Virus
12. Amino sugar compounds as antiviral and anti tumor agents
13. N-butldeoxynojirimycin-mediated inhibition of human immundeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120
14. N-butldeoxynojirimycin-mediated inhibition of human immundeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure
15. The safety and efficacy of combination therapy N-butyl deoxynojirimycin (SC-48334) and Zidovudine in patients with HIV infection and 200-500 CD4 cells/mm3
16. Combination therapy for chronic hepatitis B
17. How N linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum
18. Avoiding viral contamination in biotechnological and pharmaceutical processes
19. Large surface proteins of hepatitis b virus containing preS sequence
20. The treatment of chronic viral hepatitis
21. Hepatitis C viruses
22. Glycosylation inhibitors in biology and medicine
23. Inhibition of host ER glucosidase activity prevents Golgi processing of Bovine viral diarrhea virus E2 glycoprotein and reduces infectivity of virions
24. Antiviral chemotherapy for chronic hepatitis B infection: Lessons learned from treating HIV infected patients
25. Evidence that N glycosylation is necessary for the secretion of hepatitis B virus
26. Protease processed human hepatitis B virus is infectious for human hepatocytes, in vitro
27. The hepatitis B virus MHBs antigen is selectively sensitive to glucosidase mediated processing in the endoplasmic reticulum
28. α-glucosidase inhibitors as potential broad based antiviral agents
29. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: Therapeutic implications
30. Immunization with surface antigen vaccine alone and after treatment with L-FMAUbreaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection
31. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flavi viruses as well as members of two plant virus sub groups
32. Protein specific N glycosylation of tyrosinease and tyrosinase related protein 1 in B16 mouse melanoma cells
33. Association of folding intermediates of glycoproteins with calnexin during protein maturation
34. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis b virus DNA
35. The molecular chaperone calnexin binds G1c1Man9G1cNAc2 oligosaccharide as an initial step in recognizin unfolded glycoproteins
36. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles
37. Conformation-independent binding of monoglucosylated ribonuclease B to calnexin
38. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis agents